The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-I -based formulation. The formulation may be a MUC-I based liposomal vaccine formulation.本發明提供一種藉由投用以MUC-1為基礎之調配物予身受諸如非小細胞肺癌或前列腺癌等癌症折磨之個體,以治療該個體之方法。該調配物係為以MUC-1為基礎之脂質體疫苗調配物。